BMRN (BioMarin Pharmaceutical) Tax Rate %: 25.27% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BMRN BioMarin Pharmaceutical Inc BMRN
79 GF Score
Price $60.48
GF Value $89.18
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is BioMarin Pharmaceutical Tax Rate %?

BioMarin Pharmaceutical BMRN +0.77% 79 Tax Rate % is 25.27% as of Mar. 2026. GuruFocus rates BMRN with a GF Score™ of 79/100 and a GF Value™ of $89.18 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Tax Rate % is calculated as Tax Expense divided by its Pre-Tax Income. BioMarin Pharmaceutical's Tax Expense for the three months ended in Mar. 2026 was $36 Mil. BioMarin Pharmaceutical's Pre-Tax Income for the three months ended in Mar. 2026 was $141 Mil. Therefore, BioMarin Pharmaceutical's Tax Rate % for the quarter that ended in Mar. 2026 was 25.27%.

BioMarin Pharmaceutical Tax Rate % Related Terms

BioMarin Pharmaceutical Tax Rate % Historical Data

* Premium members only.

The historical data trend for BioMarin Pharmaceutical's Tax Rate % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioMarin Pharmaceutical Tax Rate % Chart

BioMarin Pharmaceutical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Rate %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.96 5.36 11.09 21.21 27.69

BioMarin Pharmaceutical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Rate % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.01 19.25 -16.79 -71.52 25.27
BMRN
79GF Score
BioMarin Pharmaceutical Inc BMRN
Tax Rate % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioMarin Pharmaceutical Tax Rate % Calculation

Tax Rate % is the ratio of tax expense divided by pretax income, usually presented in percent.

BioMarin Pharmaceutical's Tax Rate % for the fiscal year that ended in Dec. 2025 is calculated as

Tax Rate %=Tax Expense (A: Dec. 2025 )/Pre-Tax Income (A: Dec. 2025 )
=133.579/482.48
=27.69 %

BioMarin Pharmaceutical's Tax Rate % for the quarter that ended in Mar. 2026 is calculated as

Tax Rate %=Tax Expense (Q: Mar. 2026 )/Pre-Tax Income (Q: Mar. 2026 )
=35.676/141.203
=25.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Rate % →
What does a Tax Rate % of 25.27% mean?
BioMarin Pharmaceutical (BMRN) has a Tax Rate % of 25.27% as of Mar. 2026.
Is BioMarin Pharmaceutical's Tax Rate % too high?
BioMarin Pharmaceutical's current Tax Rate % is 25.27%. Overall, BioMarin Pharmaceutical has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioMarin Pharmaceutical's Tax Rate % compare to TECH and CYTK?
BioMarin Pharmaceutical's Tax Rate % of 25.27% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Rate % for a Biotechnology company?
A good Tax Rate % depends on the Biotechnology industry context. However, Tax Rate % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Rate % mean?
A high Tax Rate % can signal that a stock is expensive relative to its fundamentals. BioMarin Pharmaceutical's current Tax Rate % is 25.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioMarin Pharmaceutical stock overvalued right now?
Based on GuruFocus' analysis, BioMarin Pharmaceutical (BMRN) is currently considered Significantly Undervalued. The stock's GF Value™ is $89.18, compared to a current price of $60.48 — trading 32.2% below its estimated fair value. The current Tax Rate % is 25.27%. BioMarin Pharmaceutical's overall GF Score™ is 79/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Rate % calculated?
Tax Rate % is calculated from a company's financial statements. For BioMarin Pharmaceutical (BMRN), the current Tax Rate % is 25.27% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioMarin Pharmaceutical (BMRN) Overvalued in 2026?

Based on GuruFocus' analysis, BioMarin Pharmaceutical stock appears to be undervalued. The current stock price of $60.48 is trading 32.2% below its estimated GF Value™ of $89.18. GuruFocus considers BioMarin Pharmaceutical to be Significantly Undervalued.

Key valuation signals for BMRN:

  • Tax Rate %: 25.27%
  • GF Value™: $89.18 vs. price of $60.48 (32.2% below fair value)
  • GF Score™: 79/100 with 3 warning signs

No single metric tells the full story. See the BMRN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioMarin Pharmaceutical Business Description

Address 770 Lindaro Street, San Rafael, CA, USA, 94901
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
79GF Score

Get the complete analysis for BMRN

Tax Rate % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$60.48
Price
$89.18
GF Value